76045-383-30 |
76045-383 |
HUMAN PRESCRIPTION DRUG |
Neostigmine Methylsulfate |
Neostigmine Methylsulfate |
INJECTION, SOLUTION |
INTRAVENOUS |
20180918 |
N/A |
NDA |
NDA203629 |
Fresenius Kabi USA, LLC |
NEOSTIGMINE METHYLSULFATE |
1 mg/mL |
10 BLISTER PACK in 1 CARTON (76045-383-30) / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-383-13) / 3 mL in 1 SYRINGE, GLASS |
76045-214-30 |
76045-214 |
HUMAN PRESCRIPTION DRUG |
Neostigmine Methylsulfate |
Neostigmine Methylsulfate |
INJECTION, SOLUTION |
INTRAVENOUS |
20220601 |
N/A |
NDA |
NDA203629 |
Fresenius Kabi USA, LLC |
NEOSTIGMINE METHYLSULFATE |
1 mg/mL |
10 BLISTER PACK in 1 CARTON (76045-214-30) / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-214-00) / 3 mL in 1 SYRINGE, GLASS |
63323-415-36 |
63323-415 |
HUMAN PRESCRIPTION DRUG |
Neostigmine Methylsulfate |
Neostigmine Methylsulfate |
INJECTION, SOLUTION |
INTRAVENOUS |
20150108 |
N/A |
NDA |
NDA203629 |
Fresenius Kabi USA, LLC |
NEOSTIGMINE METHYLSULFATE |
1 mg/mL |
10 VIAL, MULTI-DOSE in 1 TRAY (63323-415-36) / 10 mL in 1 VIAL, MULTI-DOSE |
63323-415-10 |
63323-415 |
HUMAN PRESCRIPTION DRUG |
Neostigmine Methylsulfate |
Neostigmine Methylsulfate |
INJECTION, SOLUTION |
INTRAVENOUS |
20150108 |
N/A |
NDA |
NDA203629 |
Fresenius Kabi USA, LLC |
NEOSTIGMINE METHYLSULFATE |
1 mg/mL |
10 VIAL, MULTI-DOSE in 1 TRAY (63323-415-10) / 10 mL in 1 VIAL, MULTI-DOSE (63323-415-01) |
65219-811-10 |
65219-811 |
HUMAN PRESCRIPTION DRUG |
Neostigmine Methylsulfate |
Neostigmine Methylsulfate |
INJECTION, SOLUTION |
INTRAVENOUS |
20230109 |
N/A |
NDA |
NDA203629 |
Fresenius Kabi USA, LLC |
NEOSTIGMINE METHYLSULFATE |
1 mg/mL |
10 VIAL, MULTI-DOSE in 1 TRAY (65219-811-10) / 10 mL in 1 VIAL, MULTI-DOSE (65219-811-01) |
63323-413-36 |
63323-413 |
HUMAN PRESCRIPTION DRUG |
Neostigmine Methylsulfate |
Neostigmine Methylsulfate |
INJECTION, SOLUTION |
INTRAVENOUS |
20150108 |
N/A |
NDA |
NDA203629 |
Fresenius Kabi USA, LLC |
NEOSTIGMINE METHYLSULFATE |
.5 mg/mL |
10 VIAL, MULTI-DOSE in 1 TRAY (63323-413-36) / 10 mL in 1 VIAL, MULTI-DOSE |
63323-413-10 |
63323-413 |
HUMAN PRESCRIPTION DRUG |
Neostigmine Methylsulfate |
Neostigmine Methylsulfate |
INJECTION, SOLUTION |
INTRAVENOUS |
20150108 |
N/A |
NDA |
NDA203629 |
Fresenius Kabi USA, LLC |
NEOSTIGMINE METHYLSULFATE |
.5 mg/mL |
10 VIAL, MULTI-DOSE in 1 TRAY (63323-413-10) / 10 mL in 1 VIAL, MULTI-DOSE (63323-413-01) |